Articlo
Check my manuscript free

Taylor & Francis

Prepare your manuscript for Prion.

Review the checklist, choose your article type, and turn your draft into a cleaner submission package.

Checked 2026-08-02
Check readiness freePrepare this manuscript

Article types

Review
Clinical Trial
Research Article
Review Article
Perspective
Letter
Data Note
Registered Report
Lectio
Editorial
Methods Article
Protocol
Case Report
Systematic Review

Readiness requirements

Review the key details below, or download the complete checklist with every stored source-backed requirement.

Abstract length

  • Provide an author-written abstract of no more than 250 words.
  • Use a unstructured abstract.
Show 7 more
  • Should contain an unstructured abstract of 250 words.
  • Should contain an unstructured abstract of 200 words.
  • Should contain an structured abstract of 250 words.
  • Should be no more than 3500 for Stage 1 reports and no more than 5000 words for Stage 2, inclusive of the abstract, tables, references, figure captions, footnotes, endnotes.
  • The abstract structure should be as follows: Introduction, Methods, Results, Discussion.
  • Trial registration numbers should be included in the abstract, with full details in the methods section.
  • There are no strict formatting requirements, but all manuscripts must contain the essential elements needed to evaluate a manuscript: abstract, author affiliation, figures, tables, funder information, references.

Keywords

  • Provide 5-10 keywords chosen by the author.
  • Should contain between 5 and 10 keywords.
Show 2 more
  • Should contain between 3 and 6 keywords.
  • Should contain no more than 6 keywords.

Reference style

  • Articlo formats your supplied references to the journal's stored style and checks that citations match the reference list; source validity is not verified.
  • Provide references and brief descriptions of methods that have been published.
Show 8 more
  • For manuscripts submitted in LaTeX format a.bib reference file must be included.
  • All bibliographic entries must contain a corresponding in-text citation.
  • Readers should be able to interpret the table without reference to the text.
  • If you reply yes, you will be required to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s).
  • Letter: The letter must contain constructive criticism to an article recently published in Prion, with relevant and appropriate references, one of which should be the published Prion paper.
  • Please provide an author contributions statement at the end of your article, before the references, that outlines which author(s) were involved in the conception and design, or analysis and interpretation of the data; the drafting of the paper, revising it critically for intellectual content; and the final approval of the version to be published; and that all authors agree to be accountable for all aspects of the work.
  • The DAS should include the hyperlink, DOI or other persistent identifier associated with the data set(s), or information on how the data can be requested from the authors.
  • A declaration must be included within the submission stating: Confirmation the authors take full responsibility for the integrity of the whole content, including accuracy of references.

Figure and table rules

  • Keep every figure and table numbered, captioned, and cited in the manuscript.
  • Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour, at the correct size).
Show 4 more
  • Figures should be of sufficient resolution to enable refereeing.
  • Tables should present new information rather than duplicating what is in the text.
  • Should contain no figures.
  • Figures should be supplied in one of our preferred file formats: PS, JPEG, TIFF, or Microsoft Word (DOC or DOCX) files are acceptable for figures that have been drawn in Word.

Funding statement

  • You should declare only the acquired funds and grants that are directly relevant to the work reported in your article; for example, This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].

Competing interests

  • Include or confirm the competing interests required by the journal. Articlo checks this item and flags anything that still needs author input.

Data availability statement

  • Add or confirm the author-written Data availability statement; Articlo flags it if author input is still needed.
  • Authors are required to provide a data availability statement, detailing where data associated with a paper can be found and how it can be accessed.
Show 2 more
  • If data cannot be made open, authors should state why in the data availability statement.
  • Authors are required to cite any data sets referenced in the article and provide a Data Availability Statement.

Ethics statement

  • Add or confirm the author-written Ethics statement; Articlo flags it if author input is still needed.
  • Do not use patients' names or hospital numbers.
Show 7 more
  • In settings where ethics approval for non-interventional studies (e.g. surveys) is not required, authors must include a statement to explain this.
  • Authors should familiarise themselves with our policy on participant/patient privacy and informed consent.
  • All original research papers involving humans, animals, plants, biological material, protected or non-public datasets, collections or sites, must include a written statement in the Methods section, confirming ethical approval has been obtained from the appropriate local ethics committee or Institutional Review Board and that where relevant, informed consent has been obtained.
  • Consent All authors are required to follow the ICMJE requirements and Taylor & Francis Editorial Policies on privacy and informed consent from patients and study participants.
  • Authors must include a statement to confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any type of qualitative or quantitative research, has given informed consent to participate in the research.
  • Case Report: a clinical case report detailing their medical history, identifiable images or media content, etc), authors must include a statement to confirm that they have obtained written informed consent to publish the details from the affected individual (or their parents/guardians if the participant in not an adult or unable to give informed consent; or next of kin if the participant is deceased).
  • Case Report: For submissions where patients or participants can be potentially identified (e.g.

Blinded manuscript

  • Include or confirm the blinded manuscript required by the journal. Articlo checks this item and flags anything that still needs author input.

Cover letter

  • Using Third-Party Material in your Paper You must obtain the necessary permission to reuse third-party material in your article.
  • The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission.
Show 1 more
  • If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission.

Author contributions

  • Add or confirm the author-written Author contributions statement; Articlo flags it if author input is still needed.
  • Submitting authors should be prepared to submit CRediT roles for themselves and their co-authors (where applicable) as part of the submission process.

Title page and author information

  • All authors of a manuscript should include their full name and affiliation on the cover page of the manuscript.
  • One author will need to be identified as the corresponding author, with their email address normally displayed in the article PDF (depending on the journal) and the online article.

Article structure and word limits

  • Should be at between 2500 and 4000 words in length.
  • There should be no more than three authors and the authors cannot have more than two letters published in Prion in the last 12 months.
Show 35 more
  • Should be no more than 3000 words.
  • These instructions will ensure we have everything required so your paper can move through peer review, production and publication smoothly.
  • Please note that discounts must be applied at the Charges stage of the submission process when the APC quote is confirmed and may not be considered after submission.
  • Review: Reviews should summarise recent insights in specific research areas within the scope of the journal.
  • These should include adequate and appropriate validation to be considered.
  • Any datasets associated with the paper must publish all experimental controls and make full datasets available where possible.
  • If there are concerns about identifying factors in datasets, these should be discussed with the Editor-in-Chief prior to submission.
  • Please note, this is not required for submission but is encouraged.
  • Should be titled ‘Regarding [title of published paper]’.
  • Note that, regardless of the file format of the original submission, an editable version of the article must be supplied at the revision stage.
  • It is expected that authors should be able to provide any materials and/or protocols used in published experiments to other qualified researchers for their own use.
  • Materials include (but are not limited to): cells DNA, antibodies, reagents, organisms, mouse strains, and Drosophila strains.
  • These should be made available in a timely manner and it is acceptable to request reasonable payment to cover the cost of maintenance and transport.
  • For materials such as mutant strains and cell lines, authors should use established public repositories and provide relevant accession numbers wherever possible.
  • For all NIH/Wellcome-funded papers, the grant number(s) must be included in the declaration of interest statement.
  • Clinical Trial: Clinical trials should be registered prospectively – i.e. before participant recruitment.
  • Authors of retrospectively registered trials must be prepared to provide further information to the journal editorial office if requested.
  • Clinical Trial: The clinical trial registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization.
  • All research studies on humans (individuals, samples, or data) must have been performed in accordance with the principles stated in the Declaration of Helsinki.
  • Please include all relevant safety precautions; and cite any accepted standard or code of practice.
  • Queries Should you have any queries, please visit our Author Services website or contact us here.
  • A declaration must be included within the submission stating: Originality and accuracy of content has been confirmed by the authors.
  • Authors must provide full methodological details and adhere to relevant reporting guidelines where applicable.
  • Authors must retain the original and revised versions which must be shared upon request.
  • The PLSP guidelines for authors must be followed at all times.
  • They should provide a relevant up to date, systematic and substantial coverage of mature subjects, evaluations of progress in specified areas, and/or critical assessments of emerging technologies.
  • Data Note: Data Notes should only describe the data.
  • Papers reporting protein or DNA sequences and molecular structures should provide an accession number to any of the three major collaborative databases: DDBJ, EMBL or GenBank.
  • Please use SI units (non-italicized).
  • Clinical Trial: Clinical Trials Registry p>In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository, ideally at the beginning of the research process (prior to participant recruitment).
  • The process of obtaining consent to publish should include sharing the article with the individual (or whoever is consenting on their behalf), so that they are fully aware of the content of the article before it is published.
  • Please note that data should only be shared if it is ethically correct to do so, where this does not violate the protection of human subjects, or other valid ethical, privacy, or security concerns.
  • If you haven't submitted a paper to this journal before, you will need to create an account in Editorial Manager.
  • The VoR is the article in its final, definitive and citable form (this may not be immediately paginated, but is the version that will appear in an issue of the journal).
  • Image descriptions are typically used by systems such as pronouncing screen readers to make images accessible to people that cannot read or see the object due to a visual disability.

Reporting guidelines

  • Include or confirm the reporting guidelines required by the journal. Articlo checks this item and flags anything that still needs author input.

Preprints and prior publication

  • If you have shared an earlier version of your Author’s Original Manuscript on a preprint server, please be aware that anonymity cannot be guaranteed.

Artificial intelligence disclosure

  • Add or confirm the author-written Artificial intelligence statement; Articlo flags it if author input is still needed.
  • Please include a statement disclosing whether and how generative AI has been used in the research and manuscript preparation process.
Show 6 more
  • Use of AI tools as part of ethical research studies is permitted.
  • A declaration must be included within the submission stating: The name and version number of the AI tool used.
  • Systematic Review: Use of AI tools as part of ethically conducted literature reviews, systematic reviews, meta-analysis and bibliometrics studies is permitted.
  • Use of AI tool assisted plain language summaries (PLS) of authors own work is permitted.
  • Please read our guidance on using AI tools in your research and manuscript preparation to understand scenarios where their use may be permissible, and the required information that must be disclosed.
  • A declaration must be included within the submission stating: Confirmation the authors have checked terms of use for the specific AI tool used, and therefore confirm suitability for publication.

Article type and manuscript length

  • Research Article: There is no maximum length for a research article, but we suggest to not exceed 5000 words excluding the materials and methods and references.
  • The main text can have a maximum of 500 words.
Show 4 more
  • Research Article: Further information about the article type: Research Articles should report on original primary research.
  • Should be written with the following elements in the following order: title page; abstract; keywords; main text.
  • Should be writtenwith the elements in the following order: title page; main text; declaration of interest statement; references.
  • The article should include the title page with the authors and their affiliations, abstract and a main text with the following structure (see Preparing Your Paper): Introduction reporting a state of the art and stating the objective of the study; Results; Discussion; Materials and Methods; Acknowledgements; References; Figures with the corresponding legend below each one; and Tables.

Authorship and originality

  • Preparing Your Paper All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).

Manuscript structure

  • Data Note: Data Notes do not include any interpretation or conclusion of the data (see preparing your paper).
  • For reagents listed in the Materials and Methods section, the company that supplied the reagent and the catalog number should be listed in parentheses; do not list the company location.
Show 2 more
  • Authors must retain full records of the methods undertaken, including full descriptions and records of the prompts used, which must be shared with the journal upon request.
  • Clinical Trial: However, for clinical trials that have not been registered prospectively, Taylor & Francis journals requires retrospective registration to ensure the transparent and complete dissemination of all clinical trial results which ultimately impact human health.

Study reporting guidelines

  • For animal studies, approval must have been obtained from the local or institutional animal use and care committee.
  • Authors must provide full methodological details and adhere to relevant reporting guidelines where applicable (e.g. CONSORT-AI, STARD-AI, GAMER, TRIPOD-AI, etc).
Save journal and get updates Download complete checklist

What your package checks

Abstract: 250 words
Paper: 5,000 words
Keywords: 5-10 keywords
Declarations: Data availability, Ethics, Author contributions, Acknowledgements, Artificial intelligence

Source transparency

This preparation guide uses published journal-specific author requirements. Journal instructions can change, so authors should complete a final review before submission.

Open official guideline source